Antioxidants (Apr 2020)

Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration

  • Carmen Espinós,
  • Máximo Ibo Galindo,
  • María Adelaida García-Gimeno,
  • José Santiago Ibáñez-Cabellos,
  • Dolores Martínez-Rubio,
  • José María Millán,
  • Regina Rodrigo,
  • Pascual Sanz,
  • Marta Seco-Cervera,
  • Teresa Sevilla,
  • Andrea Tapia,
  • Federico V. Pallardó

DOI
https://doi.org/10.3390/antiox9040313
Journal volume & issue
Vol. 9, no. 4
p. 313

Abstract

Read online

: Oxidative stress is an imbalance between production and accumulation of oxygen reactive species and/or reactive nitrogen species in cells and tissues, and the capacity of detoxifying these products, using enzymatic and non-enzymatic components, such as glutathione. Oxidative stress plays roles in several pathological processes in the nervous system, such as neurotoxicity, neuroinflammation, ischemic stroke, and neurodegeneration. The concepts of oxidative stress and rare diseases were formulated in the eighties, and since then, the link between them has not stopped growing. The present review aims to expand knowledge in the pathological processes associated with oxidative stress underlying some groups of rare diseases: Friedreich’s ataxia, diseases with neurodegeneration with brain iron accumulation, Charcot-Marie-Tooth as an example of rare neuromuscular disorders, inherited retinal dystrophies, progressive myoclonus epilepsies, and pediatric drug-resistant epilepsies. Despite the discrimination between cause and effect may not be easy on many occasions, all these conditions are Mendelian rare diseases that share oxidative stress as a common factor, and this may represent a potential target for therapies.

Keywords